PIII has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PIII has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
P3 Health Partners's change in receivables for the quarter that ended in Sep. 2024 was $30 Mil. It means P3 Health Partners's Accounts Receivable declined by $30 Mil from Jun. 2024 to Sep. 2024 .
P3 Health Partners's change in receivables for the fiscal year that ended in Dec. 2023 was $-42 Mil. It means P3 Health Partners's Accounts Receivable increased by $42 Mil from Dec. 2022 to Dec. 2023 .
P3 Health Partners's Accounts Receivable for the quarter that ended in Sep. 2024 was $123 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. P3 Health Partners's Days Sales Outstanding for the three months ended in Sep. 2024 was 31.08.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. P3 Health Partners's liquidation value for the three months ended in Sep. 2024 was $-414 Mil.
The historical data trend for P3 Health Partners's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Change In Receivables | Get a 7-Day Free Trial | -9.23 | -27.37 | - | -27.18 | -42.00 |
P3 Health Partners Quarterly Data | |||||||||||||||||||
Dec18 | Dec19 | Jun20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Change In Receivables | Get a 7-Day Free Trial | -14.72 | 3.26 | -22.31 | -12.46 | 29.93 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (NAS:PIII) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
P3 Health Partners's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 123.325 | / | 362.124 | * | 91 |
= | 31.08 |
2. In Ben Graham's calculation of liquidation value, P3 Health Partners's accounts receivable are only considered to be worth 75% of book value:
P3 Health Partners's liquidation value for the quarter that ended in Sep. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 62.962 | - | 569.422 | + | 0.75 * 123.325 | + | 0.5 * 0 |
= | -414 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of P3 Health Partners's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Chicago Pacific Founders Ugp Iii, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Atul Kavthekar | officer: Chief Financial Officer | 4100 S. SAGINAW STREET, FLINT MI 48507 |
Sherif Abdou | director, officer: Chief Executive Officer | C/O P3 HEALTH GROUP HOLDINGS, LLC, 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074 |
Chicago Pacific Founders Gp Iii, L.p. | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Chicago Pacific Founders Ugp, Llc | 10 percent owner | 980 N. MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Leavitt Equity Partners Ii, L.p. | 10 percent owner | 299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Legacy, Llc | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Ii, Llc | 10 percent owner | 299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111 |
Lep Management Llc | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Taylor S. Leavitt | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Iii, L.p. | 10 percent owner, other: See Remarks | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Iii, Llc | 10 percent owner, other: See Remarks | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Cpf Iii-a Pt Spv, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Cpf Iii Pt Spv, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Erin Darakjian | officer: Interim CFO, Senior VP & CAO | C/O P3 HEALTH PARTNERS INC., 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074 |
From GuruFocus
By Business Wire • 11-27-2024
By GuruFocus Research • 03-28-2024
By Business Wire • 05-08-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 11-12-2024
By GuruFocus News • 11-11-2024
By Business Wire • 05-02-2024
By Business Wire • 04-03-2024
By GuruFocus Research • 05-09-2024
By Business Wire • 10-17-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.